Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kanuma approved in Japan to treat patients with lysosomal acid lipase deficiency

March 29, 2016

Landsteiner Genmed reports compounds for the treatment of fat accumulation

March 29, 2016

ABHD2 as a new target for developing male contraceptives

March 29, 2016

Agilis Biotherapeutics and T-TOP Clinical Research to collaborate on AADC deficiency gene therapy

March 24, 2016

Novel liver-directed glucokinase activator discovered at Advinus

March 24, 2016

RMC-035, a novel drug candidate for treating pre-eclampsia

March 24, 2016

Bayer Schering Pharma patents AKR1C3 inhibitors

March 24, 2016

Novel POLG2 variant may be associated with mitochondrial DNA depletion syndrome

March 23, 2016

Alirocumab meets primary endpoint in ODYSSEY ESCAPE trial

March 23, 2016

Phase III study of pegvaliase for treatment of PKU meets primary endpoint

March 22, 2016

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...